Selected research
Market Analysis & Forecast
Global Digital Pharmaceutical Supply Chain Management Market Analysis and Forecast 2026-2032
Market perspective
The global Digital Pharmaceutical Supply Chain Management market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Digital Pharmaceutical Supply Chain Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Digital Pharmaceutical Supply Chain Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Digital Pharmaceutical Supply Chain Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Digital Pharmaceutical Supply Chain Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Digital Pharmaceutical Supply Chain Management include McKesson Corporation, Mediceo Corporation, Palantir Technologies, Inc., Jump Technologies,Inc., InterSystems Corporation, Tecsys, Oracle, SAP and lnfor, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Digital Pharmaceutical Supply Chain Management, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Digital Pharmaceutical Supply Chain Management, also provides the revenue of main regions and countries. Of the upcoming market potential for Digital Pharmaceutical Supply Chain Management, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Digital Pharmaceutical Supply Chain Management revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digital Pharmaceutical Supply Chain Management market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digital Pharmaceutical Supply Chain Management revenue, projected growth trends, production technology, application and end-user industry.
Digital Pharmaceutical Supply Chain Management Segment by Company
McKesson Corporation
Mediceo Corporation
Palantir Technologies, Inc.
Jump Technologies,Inc.
InterSystems Corporation
Tecsys
Oracle
SAP
lnfor
Terso Solutions
CenTrak (HALMA plc)
Biolog-id
TraceLink
Digital Pharmaceutical Supply Chain Management Segment by Type
On-premise
Cloud-based
Digital Pharmaceutical Supply Chain Management Segment by Application
Planning & Analytics
Procurement
Manufacturing
Logistics
lnventory Management
Digital Pharmaceutical Supply Chain Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Pharmaceutical Supply Chain Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Pharmaceutical Supply Chain Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Pharmaceutical Supply Chain Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Digital Pharmaceutical Supply Chain Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Digital Pharmaceutical Supply Chain Management company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Pharmaceutical Supply Chain Management revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-premise
- Cloud-based
Applications
- Planning & Analytics
- Procurement
- Manufacturing
- Logistics
- lnventory Management
Companies covered
- McKesson Corporation
- Mediceo Corporation
- Palantir Technologies, Inc.
- Jump Technologies,Inc.
- InterSystems Corporation
- Tecsys
- Oracle
- SAP
- lnfor
- Terso Solutions
- CenTrak (HALMA plc)
- Biolog-id
- TraceLink
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Digital Pharmaceutical Supply Chain Management Market by Type
- 1.2.1 Global Digital Pharmaceutical Supply Chain Management Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 On-premise
- 1.2.3 Cloud-based
- 1.3 Digital Pharmaceutical Supply Chain Management Market by Application
- 1.3.1 Global Digital Pharmaceutical Supply Chain Management Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Planning & Analytics
- 1.3.3 Procurement
- 1.3.4 Manufacturing
- 1.3.5 Logistics
- 1.3.6 lnventory Management
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Digital Pharmaceutical Supply Chain Management Market Dynamics
- 2.1 Digital Pharmaceutical Supply Chain Management Industry Trends
- 2.2 Digital Pharmaceutical Supply Chain Management Industry Drivers
- 2.3 Digital Pharmaceutical Supply Chain Management Industry Opportunities and Challenges
- 2.4 Digital Pharmaceutical Supply Chain Management Industry Restraints
3 Global Growth Perspective
- 3.1 Global Digital Pharmaceutical Supply Chain Management Market Perspective (2021-2032)
- 3.2 Global Digital Pharmaceutical Supply Chain Management Growth Trends by Region
- 3.2.1 Global Digital Pharmaceutical Supply Chain Management Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Digital Pharmaceutical Supply Chain Management Market Size by Region (2021-2026)
- 3.2.3 Global Digital Pharmaceutical Supply Chain Management Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Digital Pharmaceutical Supply Chain Management Revenue by Players
- 4.1.1 Global Digital Pharmaceutical Supply Chain Management Revenue by Players (2021-2026)
- 4.1.2 Global Digital Pharmaceutical Supply Chain Management Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Digital Pharmaceutical Supply Chain Management Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Digital Pharmaceutical Supply Chain Management Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Digital Pharmaceutical Supply Chain Management Key Players Headquarters & Area Served
- 4.4 Global Digital Pharmaceutical Supply Chain Management Players, Product Type & Application
- 4.5 Global Digital Pharmaceutical Supply Chain Management Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Digital Pharmaceutical Supply Chain Management Market CR5 and HHI
- 4.6.3 2025 Digital Pharmaceutical Supply Chain Management Tier 1, Tier 2, and Tier 3
5 Digital Pharmaceutical Supply Chain Management Market Size by Type
- 5.1 Global Digital Pharmaceutical Supply Chain Management Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Digital Pharmaceutical Supply Chain Management Revenue by Type (2021-2032)
- 5.3 Global Digital Pharmaceutical Supply Chain Management Revenue Market Share by Type (2021-2032)
6 Digital Pharmaceutical Supply Chain Management Market Size by Application
- 6.1 Global Digital Pharmaceutical Supply Chain Management Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Digital Pharmaceutical Supply Chain Management Revenue by Application (2021-2032)
- 6.3 Global Digital Pharmaceutical Supply Chain Management Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 McKesson Corporation
- 7.1.1 McKesson Corporation Company Information
- 7.1.2 McKesson Corporation Business Overview
- 7.1.3 McKesson Corporation Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.1.4 McKesson Corporation Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.1.5 McKesson Corporation Recent Developments
- 7.2 Mediceo Corporation
- 7.2.1 Mediceo Corporation Company Information
- 7.2.2 Mediceo Corporation Business Overview
- 7.2.3 Mediceo Corporation Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.2.4 Mediceo Corporation Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.2.5 Mediceo Corporation Recent Developments
- 7.3 Palantir Technologies, Inc.
- 7.3.1 Palantir Technologies, Inc. Company Information
- 7.3.2 Palantir Technologies, Inc. Business Overview
- 7.3.3 Palantir Technologies, Inc. Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.3.4 Palantir Technologies, Inc. Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.3.5 Palantir Technologies, Inc. Recent Developments
- 7.4 Jump Technologies,Inc.
- 7.4.1 Jump Technologies,Inc. Company Information
- 7.4.2 Jump Technologies,Inc. Business Overview
- 7.4.3 Jump Technologies,Inc. Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.4.4 Jump Technologies,Inc. Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.4.5 Jump Technologies,Inc. Recent Developments
- 7.5 InterSystems Corporation
- 7.5.1 InterSystems Corporation Company Information
- 7.5.2 InterSystems Corporation Business Overview
- 7.5.3 InterSystems Corporation Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.5.4 InterSystems Corporation Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.5.5 InterSystems Corporation Recent Developments
- 7.6 Tecsys
- 7.6.1 Tecsys Company Information
- 7.6.2 Tecsys Business Overview
- 7.6.3 Tecsys Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.6.4 Tecsys Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.6.5 Tecsys Recent Developments
- 7.7 Oracle
- 7.7.1 Oracle Company Information
- 7.7.2 Oracle Business Overview
- 7.7.3 Oracle Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.7.4 Oracle Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.7.5 Oracle Recent Developments
- 7.8 SAP
- 7.8.1 SAP Company Information
- 7.8.2 SAP Business Overview
- 7.8.3 SAP Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.8.4 SAP Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.8.5 SAP Recent Developments
- 7.9 lnfor
- 7.9.1 lnfor Company Information
- 7.9.2 lnfor Business Overview
- 7.9.3 lnfor Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.9.4 lnfor Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.9.5 lnfor Recent Developments
- 7.10 Terso Solutions
- 7.10.1 Terso Solutions Company Information
- 7.10.2 Terso Solutions Business Overview
- 7.10.3 Terso Solutions Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.10.4 Terso Solutions Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.10.5 Terso Solutions Recent Developments
- 7.11 CenTrak (HALMA plc)
- 7.11.1 CenTrak (HALMA plc) Company Information
- 7.11.2 CenTrak (HALMA plc) Business Overview
- 7.11.3 CenTrak (HALMA plc) Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.11.4 CenTrak (HALMA plc) Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.11.5 CenTrak (HALMA plc) Recent Developments
- 7.12 Biolog-id
- 7.12.1 Biolog-id Company Information
- 7.12.2 Biolog-id Business Overview
- 7.12.3 Biolog-id Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.12.4 Biolog-id Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.12.5 Biolog-id Recent Developments
- 7.13 TraceLink
- 7.13.1 TraceLink Company Information
- 7.13.2 TraceLink Business Overview
- 7.13.3 TraceLink Digital Pharmaceutical Supply Chain Management Revenue and Gross Margin (2021-2026)
- 7.13.4 TraceLink Digital Pharmaceutical Supply Chain Management Product Portfolio
- 7.13.5 TraceLink Recent Developments
8 North America
- 8.1 North America Digital Pharmaceutical Supply Chain Management Revenue (2021-2032)
- 8.2 North America Digital Pharmaceutical Supply Chain Management Revenue by Type (2021-2032)
- 8.2.1 North America Digital Pharmaceutical Supply Chain Management Revenue by Type (2021-2026)
- 8.2.2 North America Digital Pharmaceutical Supply Chain Management Revenue by Type (2027-2032)
- 8.3 North America Digital Pharmaceutical Supply Chain Management Revenue Share by Type (2021-2032)
- 8.4 North America Digital Pharmaceutical Supply Chain Management Revenue by Application (2021-2032)
- 8.4.1 North America Digital Pharmaceutical Supply Chain Management Revenue by Application (2021-2026)
- 8.4.2 North America Digital Pharmaceutical Supply Chain Management Revenue by Application (2027-2032)
- 8.5 North America Digital Pharmaceutical Supply Chain Management Revenue Share by Application (2021-2032)
- 8.6 North America Digital Pharmaceutical Supply Chain Management Revenue by Country
- 8.6.1 North America Digital Pharmaceutical Supply Chain Management Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Digital Pharmaceutical Supply Chain Management Revenue by Country (2021-2026)
- 8.6.3 North America Digital Pharmaceutical Supply Chain Management Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Digital Pharmaceutical Supply Chain Management Revenue (2021-2032)
- 9.2 Europe Digital Pharmaceutical Supply Chain Management Revenue by Type (2021-2032)
- 9.2.1 Europe Digital Pharmaceutical Supply Chain Management Revenue by Type (2021-2026)
- 9.2.2 Europe Digital Pharmaceutical Supply Chain Management Revenue by Type (2027-2032)
- 9.3 Europe Digital Pharmaceutical Supply Chain Management Revenue Share by Type (2021-2032)
- 9.4 Europe Digital Pharmaceutical Supply Chain Management Revenue by Application (2021-2032)
- 9.4.1 Europe Digital Pharmaceutical Supply Chain Management Revenue by Application (2021-2026)
- 9.4.2 Europe Digital Pharmaceutical Supply Chain Management Revenue by Application (2027-2032)
- 9.5 Europe Digital Pharmaceutical Supply Chain Management Revenue Share by Application (2021-2032)
- 9.6 Europe Digital Pharmaceutical Supply Chain Management Revenue by Country
- 9.6.1 Europe Digital Pharmaceutical Supply Chain Management Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Digital Pharmaceutical Supply Chain Management Revenue by Country (2021-2026)
- 9.6.3 Europe Digital Pharmaceutical Supply Chain Management Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Digital Pharmaceutical Supply Chain Management Revenue (2021-2032)
- 10.2 China Digital Pharmaceutical Supply Chain Management Revenue by Type (2021-2032)
- 10.2.1 China Digital Pharmaceutical Supply Chain Management Revenue by Type (2021-2026)
- 10.2.2 China Digital Pharmaceutical Supply Chain Management Revenue by Type (2027-2032)
- 10.3 China Digital Pharmaceutical Supply Chain Management Revenue Share by Type (2021-2032)
- 10.4 China Digital Pharmaceutical Supply Chain Management Revenue by Application (2021-2032)
- 10.4.1 China Digital Pharmaceutical Supply Chain Management Revenue by Application (2021-2026)
- 10.4.2 China Digital Pharmaceutical Supply Chain Management Revenue by Application (2027-2032)
- 10.5 China Digital Pharmaceutical Supply Chain Management Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Digital Pharmaceutical Supply Chain Management Revenue (2021-2032)
- 11.2 Asia Digital Pharmaceutical Supply Chain Management Revenue by Type (2021-2032)
- 11.2.1 Asia Digital Pharmaceutical Supply Chain Management Revenue by Type (2021-2026)
- 11.2.2 Asia Digital Pharmaceutical Supply Chain Management Revenue by Type (2027-2032)
- 11.3 Asia Digital Pharmaceutical Supply Chain Management Revenue Share by Type (2021-2032)
- 11.4 Asia Digital Pharmaceutical Supply Chain Management Revenue by Application (2021-2032)
- 11.4.1 Asia Digital Pharmaceutical Supply Chain Management Revenue by Application (2021-2026)
- 11.4.2 Asia Digital Pharmaceutical Supply Chain Management Revenue by Application (2027-2032)
- 11.5 Asia Digital Pharmaceutical Supply Chain Management Revenue Share by Application (2021-2032)
- 11.6 Asia Digital Pharmaceutical Supply Chain Management Revenue by Country
- 11.6.1 Asia Digital Pharmaceutical Supply Chain Management Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Digital Pharmaceutical Supply Chain Management Revenue by Country (2021-2026)
- 11.6.3 Asia Digital Pharmaceutical Supply Chain Management Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Digital Pharmaceutical Supply Chain Management Revenue (2021-2032)
- 12.2 SAMEA Digital Pharmaceutical Supply Chain Management Revenue by Type (2021-2032)
- 12.2.1 SAMEA Digital Pharmaceutical Supply Chain Management Revenue by Type (2021-2026)
- 12.2.2 SAMEA Digital Pharmaceutical Supply Chain Management Revenue by Type (2027-2032)
- 12.3 SAMEA Digital Pharmaceutical Supply Chain Management Revenue Share by Type (2021-2032)
- 12.4 SAMEA Digital Pharmaceutical Supply Chain Management Revenue by Application (2021-2032)
- 12.4.1 SAMEA Digital Pharmaceutical Supply Chain Management Revenue by Application (2021-2026)
- 12.4.2 SAMEA Digital Pharmaceutical Supply Chain Management Revenue by Application (2027-2032)
- 12.5 SAMEA Digital Pharmaceutical Supply Chain Management Revenue Share by Application (2021-2032)
- 12.6 SAMEA Digital Pharmaceutical Supply Chain Management Revenue by Country
- 12.6.1 SAMEA Digital Pharmaceutical Supply Chain Management Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Digital Pharmaceutical Supply Chain Management Revenue by Country (2021-2026)
- 12.6.3 SAMEA Digital Pharmaceutical Supply Chain Management Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst